Prevalence and clinical manifestations of Erasmus syndrome in systemic sclerosis: a cross-sectional study

Introduction: Erasmus syndrome (ErS) is a rare entity in which Systemic Sclerosis (SSc) develops following exposure to silica, with or without associated silicosis. The objectives of this study were: 1) to evaluate the prevalence of ErS in our SSc cohort; 2) to characterize the cases; 3) to evaluate...

Full description

Bibliographic Details
Main Authors: Soraia Azevedo, Joana Sousa-Neves, Daniela Santos-Faria, Joana Leite Silva, Joana Ramos Rodrigues, Daniela Peixoto, José Tavares-Costa, Sérgio Alcino, Carmo Afonso, Filipa Teixeira
Format: Article
Language:English
Published: Sociedade Portuguesa de Reumatologia 2020-07-01
Series:Acta Reumatológica Portuguesa
Subjects:
Online Access:http://www.actareumatologica.pt/files/article/1317_prevalence_and_clinical_manifestations_of_erasmus_syndrome_in_systemic_sclerosis_a_cross_sectional_study_file.pdf
id doaj-0588a33f6cae4cd897e2924cd4d4b8c5
record_format Article
spelling doaj-0588a33f6cae4cd897e2924cd4d4b8c52020-11-25T04:09:56ZengSociedade Portuguesa de ReumatologiaActa Reumatológica Portuguesa0303-464X2020-07-0120203183190AO190140Prevalence and clinical manifestations of Erasmus syndrome in systemic sclerosis: a cross-sectional studySoraia AzevedoJoana Sousa-NevesDaniela Santos-FariaJoana Leite SilvaJoana Ramos RodriguesDaniela PeixotoJosé Tavares-CostaSérgio AlcinoCarmo AfonsoFilipa TeixeiraIntroduction: Erasmus syndrome (ErS) is a rare entity in which Systemic Sclerosis (SSc) develops following exposure to silica, with or without associated silicosis. The objectives of this study were: 1) to evaluate the prevalence of ErS in our SSc cohort; 2) to characterize the cases; 3) to evaluate the clinical and laboratory characteristics of SSc in patients with (Ers) or without silica exposure. Methods: Cross-sectional and analytical study. Sociodemographic, clinical and laboratory data were collected from all patients with SSc diagnosed in our department according to ACR / EULAR criteria. Data on professional activity and possible exposure to silica were obtained by phone interview. Results: Among 48 patients with SSc, the prevalence of ErS was 16.7% (8/48). All cases identified were male, corresponding to 72.7% of men with SSc followed at our department. There was a statistically significant association between ErS and male gender (phttp://www.actareumatologica.pt/files/article/1317_prevalence_and_clinical_manifestations_of_erasmus_syndrome_in_systemic_sclerosis_a_cross_sectional_study_file.pdfsystemic sclerosisdisease parameterssilicosisoccupational diseaseerasmus syndrome
collection DOAJ
language English
format Article
sources DOAJ
author Soraia Azevedo
Joana Sousa-Neves
Daniela Santos-Faria
Joana Leite Silva
Joana Ramos Rodrigues
Daniela Peixoto
José Tavares-Costa
Sérgio Alcino
Carmo Afonso
Filipa Teixeira
spellingShingle Soraia Azevedo
Joana Sousa-Neves
Daniela Santos-Faria
Joana Leite Silva
Joana Ramos Rodrigues
Daniela Peixoto
José Tavares-Costa
Sérgio Alcino
Carmo Afonso
Filipa Teixeira
Prevalence and clinical manifestations of Erasmus syndrome in systemic sclerosis: a cross-sectional study
Acta Reumatológica Portuguesa
systemic sclerosis
disease parameters
silicosis
occupational disease
erasmus syndrome
author_facet Soraia Azevedo
Joana Sousa-Neves
Daniela Santos-Faria
Joana Leite Silva
Joana Ramos Rodrigues
Daniela Peixoto
José Tavares-Costa
Sérgio Alcino
Carmo Afonso
Filipa Teixeira
author_sort Soraia Azevedo
title Prevalence and clinical manifestations of Erasmus syndrome in systemic sclerosis: a cross-sectional study
title_short Prevalence and clinical manifestations of Erasmus syndrome in systemic sclerosis: a cross-sectional study
title_full Prevalence and clinical manifestations of Erasmus syndrome in systemic sclerosis: a cross-sectional study
title_fullStr Prevalence and clinical manifestations of Erasmus syndrome in systemic sclerosis: a cross-sectional study
title_full_unstemmed Prevalence and clinical manifestations of Erasmus syndrome in systemic sclerosis: a cross-sectional study
title_sort prevalence and clinical manifestations of erasmus syndrome in systemic sclerosis: a cross-sectional study
publisher Sociedade Portuguesa de Reumatologia
series Acta Reumatológica Portuguesa
issn 0303-464X
publishDate 2020-07-01
description Introduction: Erasmus syndrome (ErS) is a rare entity in which Systemic Sclerosis (SSc) develops following exposure to silica, with or without associated silicosis. The objectives of this study were: 1) to evaluate the prevalence of ErS in our SSc cohort; 2) to characterize the cases; 3) to evaluate the clinical and laboratory characteristics of SSc in patients with (Ers) or without silica exposure. Methods: Cross-sectional and analytical study. Sociodemographic, clinical and laboratory data were collected from all patients with SSc diagnosed in our department according to ACR / EULAR criteria. Data on professional activity and possible exposure to silica were obtained by phone interview. Results: Among 48 patients with SSc, the prevalence of ErS was 16.7% (8/48). All cases identified were male, corresponding to 72.7% of men with SSc followed at our department. There was a statistically significant association between ErS and male gender (p
topic systemic sclerosis
disease parameters
silicosis
occupational disease
erasmus syndrome
url http://www.actareumatologica.pt/files/article/1317_prevalence_and_clinical_manifestations_of_erasmus_syndrome_in_systemic_sclerosis_a_cross_sectional_study_file.pdf
work_keys_str_mv AT soraiaazevedo prevalenceandclinicalmanifestationsoferasmussyndromeinsystemicsclerosisacrosssectionalstudy
AT joanasousaneves prevalenceandclinicalmanifestationsoferasmussyndromeinsystemicsclerosisacrosssectionalstudy
AT danielasantosfaria prevalenceandclinicalmanifestationsoferasmussyndromeinsystemicsclerosisacrosssectionalstudy
AT joanaleitesilva prevalenceandclinicalmanifestationsoferasmussyndromeinsystemicsclerosisacrosssectionalstudy
AT joanaramosrodrigues prevalenceandclinicalmanifestationsoferasmussyndromeinsystemicsclerosisacrosssectionalstudy
AT danielapeixoto prevalenceandclinicalmanifestationsoferasmussyndromeinsystemicsclerosisacrosssectionalstudy
AT josetavarescosta prevalenceandclinicalmanifestationsoferasmussyndromeinsystemicsclerosisacrosssectionalstudy
AT sergioalcino prevalenceandclinicalmanifestationsoferasmussyndromeinsystemicsclerosisacrosssectionalstudy
AT carmoafonso prevalenceandclinicalmanifestationsoferasmussyndromeinsystemicsclerosisacrosssectionalstudy
AT filipateixeira prevalenceandclinicalmanifestationsoferasmussyndromeinsystemicsclerosisacrosssectionalstudy
_version_ 1724421246131634176